Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $299,015 - $344,595
-2,341 Reduced 43.81%
3,003 $412,000
Q4 2023

Feb 14, 2024

SELL
$92.79 - $142.53 $10,299 - $15,820
-111 Reduced 2.03%
5,344 $744,000
Q3 2023

Nov 13, 2023

BUY
$128.91 - $192.44 $155,465 - $232,082
1,206 Added 28.38%
5,455 $748,000
Q2 2023

Aug 11, 2023

BUY
$183.43 - $232.67 $152,980 - $194,046
834 Added 24.42%
4,249 $796,000
Q1 2023

May 12, 2023

BUY
$193.75 - $232.55 $21,700 - $26,045
112 Added 3.39%
3,415 $794,000
Q4 2022

Feb 13, 2023

SELL
$187.24 - $242.74 $1,310 - $1,699
-7 Reduced 0.21%
3,303 $667,000
Q3 2022

Nov 10, 2022

SELL
$177.23 - $227.44 $887,213 - $1.14 Million
-5,006 Reduced 60.2%
3,310 $632,000
Q2 2022

Aug 11, 2022

BUY
$181.58 - $368.0 $749,743 - $1.52 Million
4,129 Added 98.61%
8,316 $1.53 Million
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $514,451 - $717,493
1,693 Added 67.88%
4,187 $1.46 Million
Q4 2021

Feb 14, 2022

SELL
$347.28 - $421.83 $1.12 Million - $1.35 Million
-3,211 Reduced 56.28%
2,494 $949,000
Q3 2021

Nov 12, 2021

SELL
$405.61 - $524.84 $2.13 Million - $2.76 Million
-5,256 Reduced 47.95%
5,705 $2.31 Million
Q2 2021

Aug 13, 2021

BUY
$372.84 - $481.5 $4.09 Million - $5.28 Million
10,961 New
10,961 $5.19 Million
Q1 2021

May 14, 2021

SELL
$361.28 - $504.76 $207,374 - $289,732
-574 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $168,009 - $212,931
574 New
574 $212,000
Q4 2018

Feb 13, 2019

SELL
$272.46 - $366.54 $5.07 Million - $6.82 Million
-18,618 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $5.2 Million - $6.83 Million
18,618 New
18,618 $6.83 Million
Q4 2017

Feb 13, 2018

SELL
$202.23 - $230.03 $12.7 Million - $14.5 Million
-63,012 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $10.9 Million - $13.5 Million
63,012
63,012 $12.6 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.